Switzerland started its COVID-19 vaccine rollout on Wednesday, with a care home resident in her 90s receiving the first shot just four days after the Pfizer-BioNTech vaccine was authorised.
The woman, who lives in the Lucerne region in central Switzerland, was the first person in continental Europe immunised with the Pfizer-BioNTech jab in a vaccination campaign.
Switzerland is battling stubbornly high coronavirus cases, recording around 5,000 fresh infections and 100 new deaths on Wednesday, in a country of 8.6 million people.
From Tuesday, bars and restaurants began closing again across the country in a bid to rein in the outbreak, while flights to and from Britain and South Africa have been banned following the discovery of a new variant of the virus that UK officials believe spreads far more easily.
Britain was the first country to deploy the Pfizer-BioNTech vaccine, with 90-year-old grandmother Margaret Keenan receiving the jab on December 8.
European Union countries are scheduled to start vaccinations on Sunday.
Switzerland has seen more than 421,000 infections and over 6,400 deaths since the pandemic began.
The Swissmedic regulatory authority announced on Saturday that it had approved the use of the Pfizer-BioNTech vaccine following a two-month rolling review.
The elderly and those with pre-existing conditions—two million people in total—are first in line for immunisation.
“I am very satisfied that we have now been able to start vaccinations in the canton of Lucerne,” the region’s health services chief Guido Graf said in a statement.
The neighbouring Zug canton also started vaccinating in a nursing home.
“There is great hope that the vaccinations will combat the spread of the coronavirus effectively and bring it under control,” said Zug’s cantonal health director Martin Pfister.
Among the main Swiss cities, Geneva and Basel are set to start their vaccination campaigns on Monday, while Zurich will get going on January 4.
Geneva’s hospital received its first 5,000 doses on Wednesday.
“After a month of virtual discussions, things are becoming tangible,” said Nathalie Vernaz, the cantonal pharmacist.
In early November, Geneva had the worst per capita infection rates in Europe.
Army distributing doses
Produced by US pharmaceuticals giant Pfizer and German biotechnology company BioNTech, the vaccine is based on a new technology that uses genetic material in the form of mRNA (messenger ribonucleic acid).
The Swiss army is storing and distributing the vaccine doses, which must be kept at -70 degrees Celsius (-94 degrees Fahrenheit).
It received an initial delivery of 107,000 doses on Tuesday, with 250,000 per month to follow from January.
The vaccine is not mandatory but is free of charge.
Switzerland has secured around 15.8 million COVID-19 vaccine doses, in deals with three manufacturers.
It has signed contracts for around three million doses from Pfizer-BioNTech, around 7.5 million from Moderna, and around 5.3 million from AstraZeneca.
With each of the three different vaccines, two doses are required per person.
Swiss secure three million more Moderna vaccine doses
© 2020 AFP
Swiss swift start on Covid-19 vaccinations (2020, December 23)
retrieved 23 December 2020
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022